Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Hoist Your Style: Famous Hairdos for Ladies - 2The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- 3ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025
- 4Pick Your #1 Kind Of Treat
- 5'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- Best Wellness Tracker Keep You On target
- UAE recalls some Nestle infant formula products, Qatar warns consumers
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- At least 30 killed in attack on Nigeria village
- US EPA will reassess safety of herbicide paraquat, says its chief
- Top Music and Dance Celebration: Which One Gets You Going?
- Inconceivable Spots To Stargaze All over The Planet
- From Specialist to Proficient Picture taker: Individual Triumphs
- Flash flooding causes highways to close to and from Eilat
